April 1, 2020
Drug Used to Treat Liver Disease Also Affects C. diff Life Cycle, Reduces Inflammation in Mice
The findings aid understanding of how the drug UDCA may be used in future treatment of C. diff infections in humans.
March 11, 2020
Study Shows CRISPR Effectiveness Against Colitis Pathogen
The study shows the system can be used to effectively target and eliminate the pathogen that causes the chronic, degenerative disease of the colon.
March 2, 2020
Theriot, Lanzas named University Faculty Scholars
The scholars program recognizes faculty for significant academic achievements and contributions to NC State.
July 7, 2019
CVM Researcher Awarded Grant for Innovative Disease Work
Matthew Foley has a singular focus: harnessing the body’s own power to fight off the devastating bacterium Clostridioides difficile. Now he’s getting invaluable help to reach his goal. Foley, a postdoctoral fellow at the NC State College of Veterinary Medicine, has received a prestigious National Institutes of Health T32 Training Grant to continue his promising
October 22, 2018
Grants Awarded to GI Research Projects at the CVM
Three NC State College of Veterinary Medicine researchers were awarded grants for digestive disease pilot studies at this month’s Center for Gastrointestinal Biology and Disease Research Day.
June 27, 2018
Compounds Kill C. diff, Don’t Affect Other Gut Bacteria In Vitro
NC State researchers developed a drug-testing pipeline to help identify compounds that worked against the three stages of Clostridium difficile infection, and found that a compound that holds promise for treating antibiotic-resistant bacteria may also be able to control C. difficile infections by killing the harmful bacteria without affecting other bacteria in the gut. Clostridium difficile, or C. diff, is a bacterium that
March 28, 2018
A Moveable Feast: Antibiotics Give C. diff a Nutrient-Rich Environment, No Competition
Antibiotic use creates a “banquet” for Clostridium difficile (C. diff), by altering the native gut bacteria that would normally compete with C. diff for nutrients...
April 2, 2017
Fighting Antibiotic-Resistant Bacteria in Food Animals
Responsible drug practices and antimicrobial resistance research is a CVM priority. The CVM includes faculty considered experts on such matters who shape the international conversation on approaches on drug use and antimicrobial resistance...
August 31, 2016
Theriot Earns NIH Grant to Fight Bacterial Infections
The $1.5 million grant will allow Theriot to explore new bacterial therapies to combat one of the leading hospital-acquired infections that affects more than 500,000 Americans each year...